Zobrazeno 1 - 10
of 126
pro vyhledávání: '"Cheng Wei, Tang"'
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-3 (2022)
Externí odkaz:
https://doaj.org/article/0903c4d7276943c7a5e8b2d24b04451f
Autor:
Wei FENG, Yan ZHANG, Lei LIU, Bo-yan LI, Jia-ping ZHANG, Xi CHEN, Zi-bo HE, Cheng-wei TANG, Hai-jun ZHANG, Qin-xin HAN
Publikováno v:
Transactions of Nonferrous Metals Society of China. 33:553-562
Autor:
Jin-Hang Gao, Shi-Lei Wen, Shi Feng, Wen-Juan Yang, Yao-Yao Lu, Huan Tong, Rui Liu, Shi-Hang Tang, Zhi-Yin Huang, Ying-Mei Tang, Jin-Hui Yang, Hui-Qi Xie, Cheng-Wei Tang
Publikováno v:
Angiogenesis. 26:193-196
Publikováno v:
Chinese Medical Journal, Iss 6, Pp 745-746 (2020)
Externí odkaz:
https://doaj.org/article/879dea378e054cd78e1992cdaee47377
Publikováno v:
World Journal of Clinical Cases
BACKGROUND Gastrointestinal involvement in Behçet's disease (GIBD) and Crohn’s disease (CD) are inflammatory diseases sharing a considerable number of similarities. However, different from CD, the operative and postoperative management of GIBD rem
Publikováno v:
PLoS ONE, Vol 11, Iss 3, p e0152085 (2016)
BACKGROUND:Non-alcoholic fatty liver disease (NAFLD) caused by liver lipid dysregulation is linked to obesity. Somatostatin (SST) and its analogs have been used to treat pediatric hypothalamic obesity. However, the application of such drugs for the t
Externí odkaz:
https://doaj.org/article/0cea4d2a78934d5987e3b85482ae3354
Autor:
Xiaodan Li, Liu Xiang Chen, Yi Long Chen, Bo Wei, Huan Tong, Shuai Jie Qian, Yu Hang Yang, Can Gan, Cheng Wei Tang, Yong Hong Gu, Hao Wu, Lin Hao Zhang, Zhu Yang, Zhidong Wang, Hui Huan
Publikováno v:
Journal of Digestive Diseases. 22:31-40
This study aimed to determine the risk factors and establish a risk score for post-transjugular intrahepatic portosystemic shunt (TIPS) overt hepatic encephalopathy (OHE).Altogether 299 and 62 cirrhotic patients receiving TIPS from January 2015 to Ma
Autor:
Yi Wen Chang, Chia-Lang Hsu, Hsuan Cheng Huang, Cheng Wei Tang, Xiang Jun Chen, Hsueh Fen Juan
Publikováno v:
Mol Cell Proteomics
The EGFR tyrosine kinase inhibitor gefitinib is commonly used for lung cancer patients. However, some patients eventually become resistant to gefitinib and develop progressive disease. Here, we indicate that ecto-ATP synthase, which ectopically trans
Autor:
Yi Ching Wang, Wen-Hui Kuan, Che-Chung Lin, Jayu Jen, Yi-Rong Chen, Sheng-You Liao, I-Ying Kuo, Cheng-Wei Tang, Li-Ting Wu, You-En Yang
Publikováno v:
Theranostics
Angiogenesis enhances cancer metastasis and progression, however, the roles of transcription regulation in angiogenesis are not fully defined. ZNF322A is an oncogenic zinc-finger transcription factor. Here, we demonstrate a new mechanism of Kras muta
Publikováno v:
Chinese Medical Journal, Vol 130, Iss 16, Pp 1999-2000 (2017)
Externí odkaz:
https://doaj.org/article/3a1c167a528d4ec988bcddbaf0ad1272